Masaya Oikawa
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Invasive carcinoma derived from a branch-duct intraductal papillary mucinous neoplasm without mural nodules that developed after a long-term follow-up: a case report and review of literature
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: July 12, 2026
Two Cases of Appendiceal Goblet Cell Adenocarcinoma Diagnosed after Appendectomy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
Pre-Stenting Inflammatory Burden Index (IBI) as a Predictor of Survival and Postoperative Complications in Patients with Obstructive Colorectal Cancer.
Journal: Journal of the anus, rectum and colon
Published: May 20, 2025
High-grade and Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas with STK11 Aberration Having Undergone Pancreatic Resection Three Times for Metachronous Intrapancreatic Recurrences: A Case Report and Review of the Literature.
Journal: Internal medicine (Tokyo, Japan)
Published: May 14, 2025
A Case of Unresectable Locally Advanced Pancreatic Cancer in Which Chemoradiotherapy Achieved Pathological Complete Response
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 14, 2025
Intraductal Papillary Neoplasm of the Bile Duct Occurring 37 Years after Surgery for Congenital Biliary Dilatation.
Journal: Internal medicine (Tokyo, Japan)
Published: December 18, 2024
Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery.
Journal: Surgery today
Published: June 22, 2024
Digital peroral pancreatoscopy to determine surgery for patients who have intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
Journal: Endoscopy international open
Published: May 22, 2024
ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in Pancreatic Ductal Adenocarcinoma.
Journal: Annals of surgical oncology
Published: October 06, 2023
Postoperative Carbohydrate Antigen 19-9 Level as a Good Indicator of Ineffective Response to the Currently Recommended S-1 Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma: A Single-Center, Retrospective Study.
Journal: Annals of surgical oncology
Published: June 13, 2023
Last Updated: 09/26/2026